Healthcare News and Research

Latest Healthcare News and Research

Adding drug to presurgery chemotherapy improves results for women with triple-negative breast cancer

The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.

16 Dec 2013

HCA renews contract with Florida Blue

Florida Blue and HCA announced today a contract renewal that ensures Florida Blue members will continue to have access to high quality care at HCA's 42 hospitals and 32 surgery centers throughout Florida.

16 Dec 2013

Citing security concerns, HHS says 'no' to Issa document demand

Rep. Darrell Issa has issued a subpoena to MITRE, a government contractor, to turn over documents on healthcare.gov security testing. HHS says Issa has already seen the documents he is seeking.

16 Dec 2013

Aerogen wins Medical Technology Company award for its innovative solutions to healthcare providers

Aerogen, a medical device and drug delivery company has been honoured as the Medical Technology Company of the Year Award 2013. Aerogen's patented vibrating mesh technology turns liquid medication into a fine particle mist, gently and effectively delivering drugs to the lungs of critically ill patients.

16 Dec 2013

NJHA's CEO wins FDR Visionary Award from March of Dimes

Betsy Ryan, Esq., president and CEO of the New Jersey Hospital Association, today was presented with the FDR Visionary Award from the March of Dimes, New Jersey Chapter.

15 Dec 2013

CHOP scientist receives 2013 E. Donnall Thomas Prize for scientific, clinical research in hemophilia

Katherine A. High, M.D., of The Children's Hospital of Philadelphia (CHOP) was honored for her trailblazing scientific and clinical research in the bleeding disorder hemophilia when she received the 2013 E. Donnall Thomas Prize from the American Society of Hematology (ASH) at its annual meeting on Dec. 9 in New Orleans.

15 Dec 2013

Insurers, officials try to push through website data problems to enroll new customers

A healthcare.gov website data delivery glitch is keeping insurers from fully enrolling people. In the meantime, HHS is asking insurers to allow consumers to pay premiums late and to let them temporarily see doctors who may not be on their health plans.

14 Dec 2013

Analysis provides first empirical evidence on how shared savings ACO model affect quality of care

Approximately 10 percent of Medicare spending is for cancer care, and Medicare spending is nearly four times higher for beneficiaries with cancer than in those without the disease. Little is known about how to curb spending growth while maintaining or improving quality of care for these high-risk, high-cost patients.

14 Dec 2013

Study reports increased risk of death in patients receiving anesthesia drug etomidate for surgery

Patients receiving the widely used anesthesia drug etomidate for surgery may be at increased risk or mortality and cardiovascular events, according to a study in the December issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

14 Dec 2013

Feds announce steps in effort to smooth transition to health law, avoid coverage lapses

The Obama administration announced Thursday a series of actions -- including giving consumers more time to pay their premiums and an extension of a high-risk insurance program -- to help prevent lapses in insurance coverage as key parts of the health law kick in on Jan. 1.

14 Dec 2013

High-risk pool extension gives sick Americans more time to choose a health plan

The decision will give an estimated 85,000 people who were enrolled in the pre-existing condition insurance plans created by the health law, which were originally scheduled to expire on Jan. 1, an extra month to enroll in new coverage.

14 Dec 2013

NIH publishes new informational booklet on Lewy body dementias

A new informational booklet on Lewy body dementias has been published by the National Institutes of Health for people living with LBD, their families and healthcare providers. The booklet was a collaboration among the Lewy Body Dementia Association, the Shiley-Marcos Alzheimer's Disease Research Center at the University of California, San Diego, the National Institute on Aging and National Institute of Neurological Disorders and Stroke.

14 Dec 2013

CHOP scientist receives 2013 E. Donnall Thomas Prize for research in bleeding disorder hemophilia

Katherine A. High, M.D., of The Children's Hospital of Philadelphia was honored for her trailblazing scientific and clinical research in the bleeding disorder hemophilia when she received the 2013 E. Donnall Thomas Prize from the American Society of Hematology at its annual meeting on Dec. 9 in New Orleans.

14 Dec 2013

Celebrities sell Obamacare using rap, social media

Since spring, the White House has worked with stars like Jennifer Hudson and Amy Poehler to engage 18- to 34-year-olds. Now states like California are also getting into the act, enlisting rap artists and others.

14 Dec 2013

Calif. exchange enrolls 7,100 a day, but Latinos lag

More than 156,000 have selected plans in California's online health insurance exchange, officials said, but some enrollees have not gotten confirmation from insurers, which means their policies may not start Jan. 1.

14 Dec 2013

Savient gets bankruptcy court approval to sell all assets to Crealta

Savient Pharmaceuticals, Inc. announced that it has received approval from the U.S. Bankruptcy Court for the District of Delaware to sell substantially all of the assets of Savient, including all KRYSTEXXA assets, to Crealta Pharmaceuticals LLC.

13 Dec 2013

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved the single tablet HIV-1 regimen Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) for use in certain virologically-suppressed (HIV RNA <50 copies/mL) adult patients on a stable antiretroviral regimen in order to replace their current antiretroviral treatment regimen. Complera was first approved in 2011 for patients new to therapy and is now one of the most widely-prescribed HIV regimens in the United States.

13 Dec 2013

Study shows effectiveness of PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced new results from a combined analysis of the Austrian Breast & Colorectal Cancer Study Group 8 (ABCSG-8) and Trans-Arimidex, Tamoxifen, Alone or in Combination (TransATAC) studies. These results, which evaluated samples from 2,137 patients, suggest that the PAM50-based Prosignaz Breast Cancer Prognostic Gene Signature Assay may help identify women with late distant recurrence after five years of endocrine treatment.

13 Dec 2013

Health Canada approves Genzyme's Lemtrada for adults with relapsing remitting multiple sclerosis

Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.

13 Dec 2013

Budget deal, with 3-month 'doc fix' moves to Senate

As the the House approved a budget deal, Republicans included a provision to prevent a scheduled pay cut for doctors who treat Medicare patients.

13 Dec 2013

Healthcare News and Research

Latest Healthcare News and Research

Adding drug to presurgery chemotherapy improves results for women with triple-negative breast cancer

HCA renews contract with Florida Blue

Citing security concerns, HHS says 'no' to Issa document demand

Aerogen wins Medical Technology Company award for its innovative solutions to healthcare providers

NJHA's CEO wins FDR Visionary Award from March of Dimes

CHOP scientist receives 2013 E. Donnall Thomas Prize for scientific, clinical research in hemophilia

Insurers, officials try to push through website data problems to enroll new customers

Analysis provides first empirical evidence on how shared savings ACO model affect quality of care

Study reports increased risk of death in patients receiving anesthesia drug etomidate for surgery

Feds announce steps in effort to smooth transition to health law, avoid coverage lapses

High-risk pool extension gives sick Americans more time to choose a health plan

NIH publishes new informational booklet on Lewy body dementias

CHOP scientist receives 2013 E. Donnall Thomas Prize for research in bleeding disorder hemophilia

Celebrities sell Obamacare using rap, social media

Calif. exchange enrolls 7,100 a day, but Latinos lag

Savient gets bankruptcy court approval to sell all assets to Crealta

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

Study shows effectiveness of PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay

Health Canada approves Genzyme's Lemtrada for adults with relapsing remitting multiple sclerosis

Budget deal, with 3-month 'doc fix' moves to Senate

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in